Amy Goodwin

1.3k total citations
40 papers, 855 citations indexed

About

Amy Goodwin is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Toxicology. According to data from OpenAlex, Amy Goodwin has authored 40 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 12 papers in Clinical Psychology and 10 papers in Toxicology. Recurrent topics in Amy Goodwin's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Forensic Toxicology and Drug Analysis (10 papers) and Psychedelics and Drug Studies (9 papers). Amy Goodwin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Forensic Toxicology and Drug Analysis (10 papers) and Psychedelics and Drug Studies (9 papers). Amy Goodwin collaborates with scholars based in United States, United Kingdom and Netherlands. Amy Goodwin's co-authors include Elise M. Weerts, Lisa E. Baker, William E. Fantegrossi, J. Vernikos-Danellis, Barbara J. Kaminski, Wolfgang Froestl, K. Michael Gibson, A. Daniels-Severs, Phillip R. Brown and Emily J. H. Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and American Journal of Obstetrics and Gynecology.

In The Last Decade

Amy Goodwin

38 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Goodwin United States 19 423 224 209 174 142 40 855
Dina M. Francescutti United States 12 334 0.8× 158 0.7× 161 0.8× 258 1.5× 188 1.3× 20 883
Madeleine V. King United Kingdom 16 643 1.5× 233 1.0× 211 1.0× 331 1.9× 170 1.2× 29 1.2k
Kunio Yui Japan 18 427 1.0× 108 0.5× 143 0.7× 263 1.5× 215 1.5× 71 1.1k
Lisa R. Gerak United States 20 832 2.0× 144 0.6× 78 0.4× 296 1.7× 172 1.2× 87 1.1k
Bruno Ribeiro Do Couto Spain 16 542 1.3× 67 0.3× 157 0.8× 198 1.1× 242 1.7× 29 1.0k
Michael A. Sherer United States 13 591 1.4× 200 0.9× 76 0.4× 259 1.5× 146 1.0× 18 908
S E Lukas United States 18 628 1.5× 138 0.6× 57 0.3× 276 1.6× 156 1.1× 31 1.0k
Brett C. Ginsburg United States 16 485 1.1× 150 0.7× 79 0.4× 187 1.1× 109 0.8× 62 797
Audrey Perez United States 9 685 1.6× 117 0.5× 165 0.8× 231 1.3× 266 1.9× 10 944
Cecilia Scorza Uruguay 19 301 0.7× 54 0.2× 130 0.6× 159 0.9× 192 1.4× 56 787

Countries citing papers authored by Amy Goodwin

Since Specialization
Citations

This map shows the geographic impact of Amy Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Goodwin more than expected).

Fields of papers citing papers by Amy Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Goodwin. The network helps show where Amy Goodwin may publish in the future.

Co-authorship network of co-authors of Amy Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Goodwin. A scholar is included among the top collaborators of Amy Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Goodwin. Amy Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oakley, Bethany, Alexandra Lautarescu, Tony Charman, et al.. (2025). Data sharing in child and adolescent psychiatry research: Key challenges (and some potential solutions). Open Research Europe. 5. 93–93. 1 indexed citations
2.
Goodwin, Amy, et al.. (2024). Uh and um in autism: The case of hesitation marker usage in Dutch-speaking autistic preschoolers. Journal of Child Language. 52(5). 1063–1079.
3.
Falck‐Ytter, Terje, et al.. (2023). Using the Infant Sibling-Design to Explore Associations Between Autism and ADHD Traits in Probands and Temperament in the Younger Siblings. Journal of Autism and Developmental Disorders. 54(9). 3262–3273. 1 indexed citations
4.
Shephard, Elizabeth, Iman Idrees, Priscilla Brandi Gomes Godoy, et al.. (2021). Systematic Review and Meta-analysis: The Science of Early-Life Precursors and Interventions for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 61(2). 187–226. 45 indexed citations
5.
Goodwin, Amy, Emily J. H. Jones, Luke Mason, et al.. (2021). INTERSTAARS: Attention training for infants with elevated likelihood of developing ADHD: A proof-of-concept randomised controlled trial. Translational Psychiatry. 11(1). 644–644. 10 indexed citations
6.
Goodwin, Amy, Patrick Bolton, Tony Charman, et al.. (2016). Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial. Trials. 17(1). 419–419. 21 indexed citations
7.
Goodwin, Amy, Takato Hiranita, & Merle G. Paule. (2015). The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research. Nicotine & Tobacco Research. 17(11). 1297–1310. 32 indexed citations
8.
Goodwin, Amy, et al.. (2014). Effects of adolescent treatment with nicotine, harmane, or norharmane in male Sprague–Dawley rats. Neurotoxicology and Teratology. 47. 25–35. 8 indexed citations
9.
Goodwin, Amy, K. Michael Gibson, & Elise M. Weerts. (2013). Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): Time course and severity of withdrawal in baboons. Drug and Alcohol Dependence. 132(3). 427–433. 9 indexed citations
10.
Goodwin, Amy, et al.. (2013). Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons. Journal of Pharmacology and Experimental Therapeutics. 345(3). 342–353. 4 indexed citations
11.
Goodwin, Amy, Barbara J. Kaminski, & Elise M. Weerts. (2012). Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 225(3). 637–646. 8 indexed citations
12.
Korhonen, Tellervo, et al.. (2011). Smoking Cessation Program with Exercise Improves Cardiovascular Disease Biomarkers in Sedentary Women. Journal of Women s Health. 20(7). 1051–1064. 35 indexed citations
13.
Goodwin, Amy, Phillip R. Brown, Erwin E. W. Jansen, et al.. (2009). Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 204(3). 465–476. 35 indexed citations
14.
Goodwin, Amy, Roland R. Griffiths, Phillip R. Brown, et al.. (2006). Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology. 189(1). 71–82. 19 indexed citations
15.
Struys, Eduard A., Nanda M. Verhoeven, Erwin E. W. Jansen, et al.. (2006). Metabolism of γ-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism. 55(3). 353–358. 40 indexed citations
16.
Goodwin, Amy, Wolfgang Froestl, & Elise M. Weerts. (2005). Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology. 180(2). 342–351. 36 indexed citations
17.
Weerts, Elise M., Amy Goodwin, Roland R. Griffiths, et al.. (2005). Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology. 179(3). 678–687. 32 indexed citations
18.
Goodwin, Amy & Lisa E. Baker. (2002). An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13(4). 271–278. 5 indexed citations
19.
Goodwin, Amy, et al.. (2001). Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology Biochemistry and Behavior. 68(3). 371–377. 18 indexed citations
20.
Baker, Lisa E., et al.. (1998). The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for d-amphetamine or cocaine. European Journal of Pharmacology. 358(2). 101–109. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dina M. Francescutti Breakdown of academic impact, for papers by Madeleine V. King Breakdown of academic impact, for papers by Kunio Yui Breakdown of academic impact, for papers by Lisa R. Gerak Breakdown of academic impact, for papers by Bruno Ribeiro Do Couto Breakdown of academic impact, for papers by Michael A. Sherer Breakdown of academic impact, for papers by S E Lukas Breakdown of academic impact, for papers by Brett C. Ginsburg Breakdown of academic impact, for papers by Audrey Perez Breakdown of academic impact, for papers by Cecilia Scorza
Rankless by CCL
2026